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ABSTRACT  
Multiple unit dosage forms such as microbeads have increased acceptance because of added even spreading of the drug in the gastrointestinal 
tract, unvarying drug absorption, abridged local irritation and removal of undesirable intestinal retaining of polymeric material, when 
compared to non-disintegrating single unit dosage form. The purpose of the presented research is to develop microbeads of pseudoephedrine 
hydrochloride utilizing sodium alginate as the hydrophilic carrier in combination with HPMC as drug release modifier to lessen the dosing 
frequency and thereby advance the patient compliance. The microbeads were formulated by varying concentrations of HPMC and calcium 
chloride. The optimum formulation was chosen based upon in vitro drug release studies and further evaluated. The compatibility of drug-
polymer was studied using FTIR analysis. The prepared formulation underwent evaluation for various parameters like drug entra pment, 
microbeads size, swelling index, mucoadhesive property and stability. No significant drug-polymer interactions were observed in compatibility 
studies and the formulation was found to be stable on 45 days storage. The formulations exhibited an extended drug release pa ttern which was 
the ultimate aim of the study. The microbeads represented good yield, high drug entrapment, low microbeads size and appropriate swelling 
property. The in vitro wash-off test indicated that the sodium alginate microbeads represent decent mucoadhesive properties. Henceforth, the 
formulated HPMC coated sodium alginate beads can be utilized as a substitute and cost-effective carrier for the oral controlled delivery of 
pseudoephedrine hydrochloride.  
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INTRODUCTION 
Oral drug delivery is the furthermost required and ideal way 
of administering therapeutic candidates for their systemic 
effects. Furthermore, the oral medication is largely measured 
as the initial path explored in the discovery and 
advancement of novel therapeutic entities and 
pharmaceutical preparations, chiefly owing to patient 
reception, ease and cost-effective manufacturing procedure 1. 
For ample drug candidates, controlled drug delivery system 
delivers clinically active cure while preserving the essential 
balance of pharmacokinetic and pharmacodynamic outlines 
with satisfactory level of safety to the patient 2. A controlled 
release system comprises any conveyance arrangement that 
attains deliberate release of the drug over a prolonged 
period of time, guarantees safety, efficiency of the drugs and 
patient compliance. Effective commercialization of a 
controlled release formulation is often challenging and 
comprises attention to many issues such as physiochemical 
properties of the drug, physiological factors and 
manufacturing variables 3.  
Controlled drug delivery system holds promising results in 
site-specific targeting. One of such approach is the 
formulation of microbeads as drug carriers. Multiple unit 
dosage forms such as microspheres or microbeads have 
increased acceptance because of added even spreading of the 
drug in the gastrointestinal tract, more unvarying drug 
absorption, abridged local irritation and removal of 
undesirable intestinal retaining of polymeric material, when 
compared to non-disintegrating single unit dosage form 4. 
Microbeads are small, solid and free flowing particulate 
carriers encompassing dispersed drug particles either in 
solution or crystalline form that permits a sustained release 
or multiple release profiles of treatment with various active 
agents without major side effects 5. 
Inotropic gelation method for the preparation of microbeads 
is grounded on the electrostatic interaction amongst 
polymer’s amino cluster and negatively charged assembly of 
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polyanion. Natural polysaccharides are used as biopolymers 
in novel drug delivery system, thus ensuring eco-friendly 
pharmaceutical development. Amongst the natural polymers, 
sodium alginate has been considered typically and generates 
reticulated assembly when cross-linked with polyvalent or 
divalent ions 6. Pseudoephedrine hydrochloride is a 
sympathomimetic drug efficacious for treating nasal 
congestion and vasoconstriction. Biological half-life (t1/2) of 
pseudoephedrine hydrochloride is less, furthermore it is 
sparingly water-soluble drug and exhibits a low dissolution 
rate. Pseudoephedrine hydrochloride when formulated in a 
dosage from such as tablets reveals duration of action of 3 to 
4 h, whereas when formulated as extended release form 
exhibit duration of action of 8 to 12 h 7; hence, it was thought 
worth to fabricate one such sustained release form of 
pseudoephedrine hydrochloride as microbeads. 
The aim of the presented research is to develop sustained 
release oral product namely microbeads of pseudoephedrine 
hydrochloride using sodium alginate as the hydrophilic 
carrier in combination with HPMC as drug release modifier 
to reduce the dosing frequency and thereby improve the 
patient compliance. Also, to improve its bioavailability by 
bypassing the first pass metabolism because alginate beads 
shrink and unable to swell at acidic environment and the 
encapsulated drugs are not released whereas they easily 
swell in an alkaline environment and release the drug. 
MATERIALS AND METHODS 
Preparation of alginate microbeads 
Pseudoephedrine hydrochloride microbeads were prepared 
by dissolving sodium alginate in distilled water at 800 rpm 
for 30 min to get a bubble free clear solution (2% w/v). Drug 
and polymer (HPMC) were taken (Table 1) and dispersed in 
sodium alginate solution and mixed thoroughly to form a 
smooth viscous dispersion. Resulted dispersion was 
dropwise added to calcium chloride solution (5% w/v in 
distilled water), through a needle of 20-gauge size with 
continuous stirring at the speed of 500 rpm. The cations 
diffuse into the drug loaded polymeric drops, forming a 
three-dimensional lattice of ionically cross-linked moiety. 
The resulting microbeads were collected by filtration and 
washed repeatedly with purified water to remove excess 
calcium deposited on the surface of microbeads. The 
resultant microbeads were dried under vacuum.  
Product yield 
The yield of the prepared formulations was calculated as the 
percentage of the weight of the dried product at room 
temperature compared to the theoretical amount. 
Production yield is calculated using the following equation:  
Percentage yield = [weight of product/(weight of drug + 
polymer)] × 100 
Drug entrapment efficiency 
Pseudoephedrine hydrochloride content in microbeads was 
estimated by UV-spectrophotometric method. Accurately 
weighed (50 mg) microbeads samples were added in 100 ml 
of phosphate buffer (pH 7.4) and kept for stirring for 24 h. 
The solution was filtered and the free drug concentration 
was determined spectrophotometrically at 257 nm using UV-
visible spectrophotometer. The entrapment efficiency for all 
the formulations was calculated by using following formula: 
Percent entrapment efficiency = (estimated drug 
content/theoretical drug content) × 100 
Optimization 
Various formulation variables e.g. drug concentration, 
polymer concentration, emulsifier concentration, 
concentration of cross-linking agent and process variables 
viz. stirring speed were identified and studied (Table 1). In 
order to get optimized product dissolution studies were 
carried out. 
 
Table 1: Variables applied for optimization of microbeads formulation. 
S. No. Parameter Formulation 
A1 A2 A3 A4 A5 
1 Drug 1.0 1.0 1.0 1.0 1.0 
2 HPMC 0.5 1.0 1.5 1.0 1.0 
3 Sodium alginate 2.0 2.0 2.0 2.0 2.0 
4 Calcium chloride 5.0 5.0 5.0 3.0 7.0 
 
In vitro drug release studies 
The in vitro drug release studies of drug loaded microbeads 
were carried out using USP dissolution apparatus type I in 
different mediums. Microbeads were weighed (100 mg) and 
gently spread over the surface of 900 ml of dissolution 
medium. The content was rotated at 50 rpm at 37 ± 0.5 °C. 
Perfect sink condition was maintained during drug 
dissolution study period. The simulation of gastrointestinal 
transit condition was achieved by altering the pH of 
dissolution medium at different time intervals. The pH of 
dissolution medium was maintained at 1.2 for 2 h using 0.01 
N HCl. The medium was filtered through membrane filter 
(0.45 µm), after few hours when the sample were withdrawn 
the residue on filter paper was added to the next medium 
immediately, that is phosphate buffer pH 7.4 and the 
samples (10 ml) were withdrawn at particular time intervals 
of 15 min from another medium as well. The samples were 
analysed using UV-visible spectrophotometer at 257 nm for 
drug release. The receptor volume was maintained constant 
by replacing with equivalent volume of medium after each 
withdrawal. The drug concentration was calculated using 
regression equation of the calibration curve.  
Drug-polymer compatibility study in microbeads 
Compatibility studies in optimized formulation were 
performed using Fourier Transform infrared (FTIR) 
spectroscopic analysis. To check the compatibility of the 
pseudoephedrine hydrochloride with polymer, IR spectra of 
drug, polymer and combination of the drug and polymer 
were taken on an FTIR spectrophotometer in the wave 
number region of 400 and 4000 cm-1. 
Measurement of microbeads size by optical microscopy 
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Size of the prepared microbeads in optimized formulation 
was determined using an optical microscope fitted with a 
stage and an ocular micrometre. Mean diameter was 
calculated by measuring diameter of 50 mg dried 
microbeads of formulation. 
Swelling index study 
The extent of swelling was measured in terms of percent 
weight gain by the beads. In this test 20 mg of beads was 
kept in petri dish containing phosphate buffer (pH 7.4). At 
the end of 1 h, the beads were withdrawn, soaked with 
tissue paper and weighed. Then for every 1 h, weights of 
beads were noted and the process was continued till the end 
of 8 h. The percent weight gain by the beads was calculated 
by the following formula:  
Swelling index (SI) = [(Wt – W0)/W0] × 100 
Where, Wt = mass of swollen beads at time t, W0 = mass of 
dry beads at t = 0 
Mucoadhesive test 
The mucoadhesive property of microbeads was evaluated by 
an in vitro adhesion testing method known as wash-off 
method. Freshly excised pieces of chicken intestinal mucosa 
were mounted on to glass slides with cotton thread. About 
20 microbeads were spread on to each prepared glass slide 
and immediately thereafter the slides were hung to USP II 
tablet disintegration test apparatus. When the test apparatus 
was operated, the sample is subjected to slow up and down 
movement in the test fluid at 37 °C contained in a one litre 
vessel of the apparatus. At an interval of 30 min up to 8 h, 
the machine was stopped and number of beads still adhering 
to mucosal surface was counted. The test was performed at 
intestinal (phosphate buffer pH 7.4) condition. 
Stability studies 
To assess the long-term physical stability, microbeads from 
were filled into a hard gelatin capsules manually and 
wrapped the filled capsule with aluminium foil and entire 
packet was kept in to self-sealing polyethylene cover. The 
stability studies were performed at room temperature for 
period of 45 days. Particle size studies (with optical 
microscope) and drug content analysis 
(spectrophotometrically at 257 nm) were conducted every 7 
days for the entire period of stability study. 
RESULTS AND DISCUSSION 
Chemical reaction between sodium alginate and calcium 
chloride to form calcium alginate was utilized for the 
microencapsulation of pseudoephedrine hydrochloride core 
material. For slowing the drug release hydrophilic polymers 
were added in different concentration so that the drug will 
release constantly for 24 h. The yield of all the formulations 
was found to be in the range of 77.23 ± 0.35 to 89.87 ± 
0.46%. The drug entrapment efficiency determines the 
percentage of encapsulated drug with respect to the total 
drug introduced into polymer solution. Our study indicated 
that the drug entrapment efficiency for various formulations 
of pseudoephedrine hydrochloride in microbeads was found 
to be in range of 76.30 ± 0.38 to 92.14 ± 0.54% (Table 2).  
 
 
Table 2: Percentage yield and drug entrapment efficiency of various microbeads formulation of pseudoephedrine 
hydrochloride (n=3). 
Formulation Percentage Yield 
(Mean ± S.E.M.) 
Drug Entrapment Efficiency  
(Mean ± S.E.M.) 
A1 77.23 ± 0.35 86.23 ± 0.51 
A2 86.90 ± 0.50 92.14 ± 0.54 
A3 89.87 ± 0.46 88.75 ± 0.46 
A4 79.34 ± 0.41 80.86 ± 0.48 
A5 83.45 ± 0.46 76.30 ± 0.38 
 
 
It is obvious that increasing calcium chloride concentration 
produces beads with higher levels of Ca2+ ions. 
Consequently, the cross-linking of the polymer and 
compactness of the formed insoluble dense matrices also 
increases, resulting in more drug entrapment in the 
microbeads. On other hand further increase in the 
concentration of calcium chloride above (5% w/v) do not 
enhance the drug loading. This could be due to possible 
saturation of calcium binding sites in the guluronic acid 
chain, preventing further Ca2+ ions entrapment and, hence, 
cross-linking was not altered with higher concentration of 
calcium chloride solution 8. Therefore, the percentage of 
calcium chloride in our study was chosen in such a manner 
to get maximum drug loading efficiency. 
Dissolution studies were carried out for formulation 
optimization. Firstly, we observed the dissolution profile of 
prepared microbeads in 0.01N HCl and phosphate buffer (pH 
7.4) by varying the concentration of polymer (HPMC) and 
keeping rest of the excipients unchanged. Dissolution rate 
was found out to be increased with an increase in time. 
Amongst formulations with various drug polymer ratio viz. 
1:0.5, 1:1 and 1:1.5, the formulation with 1:1 ratio exhibited 
best drug release, hence optimized for other preparations 
(Figure 1). 
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Figure 1: In vitro drug release studies for pseudoephedrine hydrochloride loaded alginate microbeads prepared using 
varying concentration of HPMC. 
 
Calcium chloride is mainly used for crosslinking. We used 
varying concentrations (3%, 5% and 7% w/v) of calcium 
chloride in our previously optimized formulation. It was 
found that, at lower concentration (3%) dissolution 
increased whereas at higher concentration (7%), dissolution 
decreased. Hence, the best results were obtained with 5% 
calcium chloride (Figure 2). Hence, the formulation A2 with 
drug:polymer:sodium alginate:calcium chloride as 1:1:2:5, 
has been optimized and utilized for further studies. 
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Figure 2: In vitro drug release studies for pseudoephedrine hydrochloride loaded alginate microbeads prepared using 
varying concentration of calcium chloride. 
 
The compatibility of pseudoephedrine hydrochloride with 
various polymers was investigated by FTIR-spectroscopy 
study. The IR spectra of the drug and polymer combination 
were compared with the spectra of the pure drug. In which 
no shifting of peaks was significantly found, indicating the 
stability of the drug during encapsulation process. The mean 
particle size of optimized formulation of pseudoephedrine 
hydrochloride microbeads was found to be 867.45 ± 3.08 μm. 
It has been specified that when a drop of alginate solution 
comes in contact with calcium ions, gelation occurs 
instantaneously. As Ca+2 ions, penetrates into interior of 
droplets, water is squeezed out of the interior of droplets 
resulting in contraction of beads 9. The size of the spherical 
matrix could easily be controlled by varying the stirring 
speed and cross-linking time of the system. The swelling 
behaviour of the beads was studied by measuring the weight 
of the beads after exposure to phosphate buffer, pH 7.4 for 8 
h. Degree of swelling is proportional to ratio of drug to 
polymer and it affects the property of drug release from 
polymer. The mean swelling index of optimized formulation 
of pseudoephedrine hydrochloride microbeads was found to 
be 62.35 ± 0.14% (Table 3). Under neutral conditions the 
beads swell and the drug release depends on the swelling 
and erosion process. Being a polyelectrolyte, alginate can 
exhibit swelling properties that are sensitive to the pH, ionic 
strength and ionic composition of the medium 10. The 
optimized batch was subjected to mucoadhesive test and 
formulation A2 exhibited 80.71 ± 0.55% mucoadhesive 
property. The optimized formulation was subjected to 
stability studies at room temperature 45 days. Thereafter, 
the beads size and drug content were determined. Results 
from the stability studies indicated that beads were 
physically and chemically stable for more than 45 days, 
exhibiting no significant change in bead size and drug 
content.
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Table 3: Evaluation parameters of alginate microbeads formulation of pseudoephedrine hydrochloride 
 
Optimized Batch 
Microbeads size (μm) Swelling index (%) Mucoadhesion (%) 
Mean ± S.E.M. (n=3) 
A2 867.45 ± 3.08 62.35 ± 0.14 80.71 ± 0.55 
 
 
CONCLUSION 
Pseudoephedrine hydrochloride microbeads were 
successfully prepared by ionotropic gelation method. Among 
the batches, A2 exhibited better drug release and further 
used to determine the microbead size, swelling index, 
mucoadhesive property and stability. All the evaluated 
parameters found to be in promising range. Therefore, it can 
be assumed that the pseudoephedrine hydrochloride 
microbeads are promising pharmaceutical dosage forms, 
which provide sustained release drug delivery system and 
improve bioavailability. The entire process is feasible in an 
industrial scale and can be applied for further pilot study. 
CONFLICT OF INTEREST 
The author does not have any conflict of interest. 
REFERENCES 
1. Sherina VM, Santhi K, Sajeeth CI, “Formulation and evaluation 
of sodium alginate microbeads as a carrier for the controlled 
release of nifedipine” IJPCS, 2012; 1(2):699-710. 
2. Manjanna KM, Shivakumar B, Pramodkumar TM, “Diclofenac 
sodium microbeads for oral sustained drug delivery” Int J 
Pharm Tech Res, 2009; 1(9):317-327. 
3. Lachman L, Lieberman HA, Kanig JL. The theory and practice 
of industrial pharmacy. 3rd ed. Mumbai: Varghese Publishing 
House; 1987. P. 230. 
4. Malik RK, Malik P, Gulati N, Nagaich U, “Fabrication and in 
vitro evaluation of mucoadhesive ondansetron hydrochloride 
beads for the management of emesis in chemotherapy” Int J 
Pharm Invest, 2013; 3(1):42-46. 
5. Menon TV, Sajeeth CI, “Formulation and evaluation of 
sustained release sodium alginate microbeads of carvedilol” 
Int J Pharm Tech Res, 2013; 5(2):746-753. 
6. Mattam J, Sailaja K, “Preparation and evaluation of 
sulfasalazine loaded sodium alginate microbeads for 
sustained delivery” AJPCR, 2016; 9(2):66-70. 
7. Joe VF, Prasanth VV, Viswanath BA et al., “Formulation and 
evaluation of pseudoephedrine hydrochloride and loratadine 
extended release tablet” J Pharm Res, 2011; 4(2):507-508. 
8. Rastogi R, Sultan Y, Aqil M, “Alginate microspheres of 
isoniazid for oral sustained drug delivery” Int J Pharm, 2007; 
334(1-2):71-77.  
9. Pralhad TT, Rajendra Kumar DK, “Encapsulation of water-
insoluble drugs by a cross-linking technique” AAPS Pharm Sci, 
2004; 6(12):1-8.  
10. Sevgi T, Omer HO, Fusun A, “Formulation and investigation of 
nicardipine HCl-alginate gel beads with factorial design-based 
studies” Euro J Pharm Sci, 1998; 6(3):241-246. 
 
 
